Detalhe da pesquisa
1.
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial.
Ann Hematol
; 103(3): 855-868, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112795
2.
Autologous hematopoietic stem cell transplantation improves survival outcomes in peripheral T-cell lymphomas: a multicenter retrospective real-world study.
Ann Hematol
; 102(11): 3185-3193, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37700194
3.
High-purity orbital angular momentum vortex beam generator using an amplitude-and-phase metasurface.
Opt Lett
; 46(23): 5790-5793, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34851891
4.
High-dose dexamethasone plus recombinant human thrombopoietin vs high-dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial.
Am J Hematol
; 95(12): 1542-1552, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32871029
5.
Daratumumab added to standard of care in patients with newly diagnosed multiple myeloma: A network meta-analysis.
Eur J Haematol
; 103(6): 542-551, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31444819
6.
A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia.
Am J Hematol
; 94(12): 1374-1381, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31591739
7.
Comparison of CD4/6 inhibitors, PI3K inhibitors, and mTOR inhibitors for patients with advanced HR+/HER2- Breast cancer: A network meta-analysis of 19 RCTs.
Breast J
; 26(9): 1862-1866, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32037589
8.
CDK4/6 inhibitors plus endocrine therapy improve overall survival in advanced HR+/HER2- breast cancer: A meta-analysis of randomized controlled trials.
Breast J
; 26(7): 1439-1443, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31828901
9.
Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma.
Signal Transduct Target Ther
; 9(1): 99, 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627366
10.
[Multicenter Prospective Study of Different Induction Regimens of Azacytidine in Treatment of Elderly Patients with Acute Myeloid Leukemia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 31(4): 1005-1013, 2023 Aug.
Artigo
em Zh
| MEDLINE | ID: mdl-37551469
11.
Efficacy and safety of QL0911 in adult patients with chronic primary immune thrombocytopenia: A multicenter, randomized, double-blind, placebo-controlled, phase III trial.
J Transl Int Med
; 11(4): 423-432, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38130645
12.
Novel agents-based regimens as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials.
Hematol Oncol
; 30(2): 57-61, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21809367
13.
[Clinical Comparation of Two Kinds of Chemotherapy Regimens in the Treatment of Patients with MDS-RAEB/AML-MRC].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 28(3): 894-898, 2020 Jun.
Artigo
em Zh
| MEDLINE | ID: mdl-32552954
14.
Comparison of acalabrutinib plus obinutuzumab, ibrutinib plus obinutuzumab and venetoclax plus obinutuzumab for untreated CLL: a network meta-analysis.
Leuk Lymphoma
; 61(14): 3432-3439, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32862749
15.
A meta-analysis of autologous transplantation for newly diagnosed multiple myeloma in the era of novel agents.
Leuk Lymphoma
; 60(6): 1381-1388, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30516074
16.
Carfilzomib/pomalidomide single-agent or in combination with other agents for the management of relapsed/refractory multiple myeloma: a meta-analysis of 37 trials.
Oncotarget
; 8(24): 39805-39817, 2017 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27458170
17.
Analysis of clinical effects and mechanism of recombinant human interleukin-11 with glucocorticoids for treatment of idiopathic thrombocytopenic purpura.
Exp Ther Med
; 13(2): 519-522, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28352325
18.
[Ratio of Primary Bone Marrow Cells after Induction Chemothrapy for Two Weeks in the Patients with Ph- ALL and Its Influence on Complete Remission and Overall Progrosis].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 25(3): 749-753, 2017 Jun.
Artigo
em Zh
| MEDLINE | ID: mdl-28641629
19.
[Prospective multicentre study of chemotherapeutic regimen containing pirarubicin on the treatment of relapsed or refractory acute myeloid leukemia in adults].
Zhonghua Xue Ye Xue Za Zhi
; 35(5): 388-92, 2014 May.
Artigo
em Zh
| MEDLINE | ID: mdl-24857206
20.
[The influence of CD44 on the adhesive, migratory and infiltrative abilities of leukemia cells].
Zhonghua Xue Ye Xue Za Zhi
; 34(1): 60-3, 2013 Jan.
Artigo
em Zh
| MEDLINE | ID: mdl-23597468